A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Clinical trial NCT02321293 · UNKNOWN
Trial details
- NCT number
- NCT02321293
- Sponsor
- Lady Davis Institute
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.